[go: up one dir, main page]

ATE204296T1 - Verfahren zur herstellung von 1-desamino-8-d- arginin-vasopressin - Google Patents

Verfahren zur herstellung von 1-desamino-8-d- arginin-vasopressin

Info

Publication number
ATE204296T1
ATE204296T1 AT94920616T AT94920616T ATE204296T1 AT E204296 T1 ATE204296 T1 AT E204296T1 AT 94920616 T AT94920616 T AT 94920616T AT 94920616 T AT94920616 T AT 94920616T AT E204296 T1 ATE204296 T1 AT E204296T1
Authority
AT
Austria
Prior art keywords
arginine vasopressin
ddavp
gln
cys
asn
Prior art date
Application number
AT94920616T
Other languages
English (en)
Inventor
Bo Ake Krister Larsson
Thomas Bjoern Mellbrand
Ewa Maria Birgitta Moernstam
Jan Anders Ingemar Roschester
Jan-Ake Skoeldbaeck
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Application granted granted Critical
Publication of ATE204296T1 publication Critical patent/ATE204296T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/16Oxytocins; Vasopressins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
AT94920616T 1993-06-29 1994-06-22 Verfahren zur herstellung von 1-desamino-8-d- arginin-vasopressin ATE204296T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/084,847 US5500413A (en) 1993-06-29 1993-06-29 Process for manufacture of 1-deamino-8-D-arginine vasopressin
PCT/SE1994/000621 WO1995001373A1 (en) 1993-06-29 1994-06-22 Process for manufacture of 1-deamino-8-d-arginine vasopressin

Publications (1)

Publication Number Publication Date
ATE204296T1 true ATE204296T1 (de) 2001-09-15

Family

ID=22187597

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94920616T ATE204296T1 (de) 1993-06-29 1994-06-22 Verfahren zur herstellung von 1-desamino-8-d- arginin-vasopressin

Country Status (14)

Country Link
US (1) US5500413A (de)
EP (1) EP0710247B1 (de)
JP (1) JP3453144B2 (de)
KR (1) KR0163224B1 (de)
CN (1) CN1040648C (de)
AT (1) ATE204296T1 (de)
CA (1) CA2166297C (de)
DE (1) DE69427985T2 (de)
DK (1) DK0710247T3 (de)
ES (1) ES2159562T3 (de)
GR (1) GR3036935T3 (de)
HK (1) HK1000910A1 (de)
PT (1) PT710247E (de)
WO (1) WO1995001373A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69424940T2 (de) * 1993-06-29 2000-12-28 Ferring B.V., Hoofdorp Synthese zyklischer peptide
US5674850A (en) * 1993-12-23 1997-10-07 Ferring Ab High purity desmopressin produced in large single batches
SE9400918L (sv) * 1994-03-18 1995-09-19 Anne Fjellstad Paulsen Stabiliserad komposition för oral administrering av peptider
US5763398A (en) * 1996-06-20 1998-06-09 Ferring B.V. Nasal administration of desmopressin
US5922680A (en) * 1996-10-23 1999-07-13 Ferring, B.V. Stabilized composition for oral administration of peptides
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
WO2003079972A2 (en) 2002-02-22 2003-10-02 New River Parmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
DE602004001727T2 (de) * 2003-04-07 2007-08-02 Novetide Ltd. Verfahren zur herstellung cyclischer peptide
CA2545194C (en) * 2003-11-10 2014-10-21 Seymour H. Fein Pharmaceutical compositions including low dosages of desmopressin
PT1530967E (pt) * 2003-11-13 2006-09-29 Ferring Bv Embalagem blister e uma forma de dosagem solida que compreende desmopressina.
SE528446C2 (sv) * 2006-03-02 2006-11-14 Ferring Int Ct Sa Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
AU2007292253A1 (en) * 2006-09-08 2008-03-13 Wyeth Arginine wash in protein purification using affinity chromatography
CA2988753A1 (en) 2007-08-06 2009-02-12 Serenity Pharmaceuticals, Llc Methods and devices for desmopressin drug delivery
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
PT3225250T (pt) * 2008-05-21 2019-10-15 Ferring Bv Desmopressina orodispersivel para aumentar o periodo inicial de sono não perturbado pela nocturia
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
PT4104848T (pt) 2009-06-18 2024-01-04 Acerus Pharmaceuticals Usa Llc Administração segura de desmopressina
JO3371B1 (ar) * 2013-07-26 2019-03-13 Ferring Bv ناهضات مستقبل فاسوبريسين 2

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH495957A (de) * 1966-09-15 1970-09-15 Ceskoslovenska Akademie Ved Verfahren zur Herstellung eines antidiuretisch wirksamen Polypeptids
US4271068A (en) * 1968-05-10 1981-06-02 Ciba-Geigy Corporation Process for the manufacture of cystine-containing peptides
CH517705A (de) * 1969-12-16 1972-01-15 Ciba Geigy Ag Verfahren zur Herstellung von Cystin-haltigen Peptiden
ZA733419B (en) * 1972-07-04 1974-03-27 Hoffmann La Roche Nonapeptides and process for the preparation thereof
US3929758A (en) * 1974-09-12 1975-12-30 Armour Pharma Cyclization of cysteine-containing peptides
US4033940A (en) * 1975-11-12 1977-07-05 Armour Pharmaceutical Company Cyclization of peptides
US4093610A (en) * 1977-01-31 1978-06-06 American Home Products Corporation Process for producing triglycyl-lysine vasopressin and intermediates therefor
US4216141A (en) * 1978-07-19 1980-08-05 The Salk Institute For Biological Studies Method for cyclization of peptides
DE2923787A1 (de) * 1979-06-12 1980-12-18 Max Planck Gesellschaft Verfahren zur selektiven bildung von disulfidbruecken in polypeptiden und die dabei erhaltenen produkte als wirkstoffe enthaltende arzneimittel
IE56021B1 (en) * 1982-10-13 1991-03-27 Akzo Nv Peptides
SE8306367L (sv) * 1983-11-18 1985-05-19 Ferring Ab Antidiuretiskt verkande farmaceutiskt preparat
US5066716A (en) * 1988-12-13 1991-11-19 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Synthesis of chloroacetyl and bromoacetyl modified peptides for the preparation of synthetic peptide polymers, conjugated peptides, and cyclic peptides

Also Published As

Publication number Publication date
ES2159562T3 (es) 2001-10-16
KR960703411A (ko) 1996-08-17
CN1040648C (zh) 1998-11-11
DE69427985T2 (de) 2002-03-28
KR0163224B1 (ko) 1998-11-16
CA2166297A1 (en) 1995-01-12
WO1995001373A1 (en) 1995-01-12
EP0710247A1 (de) 1996-05-08
CN1125952A (zh) 1996-07-03
JP3453144B2 (ja) 2003-10-06
CA2166297C (en) 2001-03-27
EP0710247B1 (de) 2001-08-16
HK1000910A1 (en) 2002-03-15
PT710247E (pt) 2001-12-28
DE69427985D1 (de) 2001-09-20
GR3036935T3 (en) 2002-01-31
DK0710247T3 (da) 2001-10-01
US5500413A (en) 1996-03-19
JPH09502423A (ja) 1997-03-11

Similar Documents

Publication Publication Date Title
ATE204296T1 (de) Verfahren zur herstellung von 1-desamino-8-d- arginin-vasopressin
IE901673L (en) Enzymatic removal of a protein amino-terminal sequence
EP0233838A3 (de) Neuriten stimulierender Faktor und Prozess für seine Herstellung
DK1396542T3 (da) P-selectin ligand protein
ES8504255A1 (es) Procedimiento para la produccion de una hormona de crecimiento de porcino.
DE69715860D1 (de) Verfahren zur herstellung von peptiden
EP0927756A4 (de) Proteine mit zellulase-aktivitäten und prozess für ihre herstellung
DE3687006D1 (de) Verfahren zur herstellung von 2-alkoxy-n-(1-azabicyclo(2.2.2)octan-3-yl)aminobenzamiden.
ES488382A1 (es) Procedimiento para la preparacion de lh-rh o de analogos de lh-rh
DE3380819D1 (en) A precursor of a c-terminal amidated peptide and production thereof
CA2011378A1 (en) Achromobacter protease i gene and gene product thereof
ATE99662T1 (de) Verfahren zur herstellung von 1,1-dichlor-1fluorethan.
DE59813491D1 (de) Verfahren zur Herstellung eines eine Hyaluronidase enthaltenden Präparats
JPS57149823A (en) Purifying method for brine for electrolysis
EP0106282A3 (de) Herstellung einer Caerulein-Zwischenverbindung
PT73587A (en) Process for preparing novel peptides
ES8505939A1 (es) Procedimiento para preparar compuestos que contienen grupos amida de acido carboxilico
JPS6483058A (en) Novel tripeptide compound
EP0625580A4 (en) Novel hirudine variant, process for producing the same, and anticoagulant containing the same as active ingredient.
JPS6460391A (en) Production of gamma-halo-beta(r)-hydroxybutyric acid ester
ATE33854T1 (de) Verfahren zur biotechnischen herstellung von l|pfels|ure.
TW243453B (en) Cloning and characterization of a cardiac adenylyl cyclase
NO921496L (no) Fremgangsmaate for fremstilling av et peptid eller proteinbeslektet med det melanomaforbundne p97-antigen
HUT40993A (en) Process for production of esthers of o /2,6-dichlorphenilamino/-phenil-acetic acid
CA1267086C (en) METHOD OF ADMINISTRATION OF EAR DIURETIC PEPTIDES